Retrospective analysis of third-line chemotherapy in advanced non-small cell lung cancer | Zendy

AliMurat Tatli | Zendy; Deniz Arslan | Zendy; Mükremın Uysal | Zendy; SemaSezgin Goksu | Zendy; Samime Şarlı Gündüz | Zendy; HasanŞenol Coşkun | Zendy; Mustafa Özdoğan | Zendy; Burhan Savaş | Zendy; HakanSat Bozcuk | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Retrospective analysis of third-line chemotherapy in advanced non-small cell lung cancer

Author(s) -

AliMurat Tatli,

Deniz Arslan,

Mükremın Uysal,

SemaSezgin Goksu,

Samime Şarlı Gündüz,

HasanŞenol Coşkun,

Mustafa Özdoğan,

Burhan Savaş,

HakanSat Bozcuk

Publication year - 2015

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.146092

Subject(s) - oncology , chemotherapy , lung cancer , medicine , retrospective cohort study

First- and second-line chemotherapies have been demonstrated to be effective in treatment of patients with inoperable, advanced non-small cell lung cancer (NSCLC), although the role of third-line chemotherapy remains unclear. The present investigation assessed treatment outcomes in patients with advanced NSCLC who received third-line and higher chemotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research